Incidence of xerostomia and effectiveness of oral xyletol in xerostomia management among hemodialysis patients
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20253368Keywords:
Chronic kidney disease, Hemodialysis, Incidence, Oral XYLETOL, XerostomiaAbstract
Background: Xerostomia or dryness of the mouth, is a frequent complaint among patients undergoing chronic haemodialysis (HD). However, its incidence and severity in dialysis populations, particularly in tropical regions like India, remain poorly documented. Xerostomia may contribute to intradialytic weight gain (IWG) by influencing fluid intake behaviours, but its role in this context is unclear. This study is aimed to assess the incidence of xerostomia in dialysis patients and evaluate the effectiveness of oral XYLETOL in its management.
Methods: This prospective study included CKD stage 5D patients aged 18-75 years, on dialysis for at least 3 months. Xerostomia was assessed using a validated questionnaire, with scores ≥25 indicating significant xerostomia. Patients consenting to further evaluation were administered oral XYLETOL tablets (2 tablets, three times daily, 2 hours after meals) for four weeks. Xerostomia inventory scores were reassessed after treatment and compared with baseline scores. Secondary assessments included intradialytic weight gain (IWG) and hypotension episodes.
Results: The study demonstrated that oral XYLETOL tablets effectively reduced xerostomia symptoms in HD patients with significant scores (≥25). Post-treatment xerostomia scores showed notable improvement compared to baseline. However, no significant impact was observed on IWG, indicating that the benefits were confined to symptom relief rather than on hemodynamic changes.
Conclusions: Xerostomia in HD patients has multiple contributing factors, including advanced age, systemic diseases, medication use, fluid intake restrictions and salivary gland fibrosis. Early identification of risk factors is crucial for effective management. While XYLETOL is beneficial for reducing xerostomia.
Metrics
References
Davison SN, Jhangri GS. Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients. J Pain Symptom Manage. 2010;39(3):477-85. DOI: https://doi.org/10.1016/j.jpainsymman.2009.08.008
Abdel-Kader K, Unruh ML, Weisbord SD. Symptom burden, depression and quality of life in chronic and end-stage kidney disease. Clin J Am Soc Nephrol. 2009;4(6):1057-64. DOI: https://doi.org/10.2215/CJN.00430109
Yong DS, Kwok AO, Wong DM, Suen MHP, Chen WT, Tse DMW. Symptom burden and quality of life in end-stage renal disease: a study of 179 patients on dialysis and palliative care. Palliat Med. 2009;23(2):111-9. DOI: https://doi.org/10.1177/0269216308101099
Weisbord SD, Bossola M, Fried LF, Stefania G, Tazza L, Palevsky PM, et al. Cultural comparison of symptoms in patients on maintenance hemodialysis. Hemodial Int. 2008;12(4):434-40. DOI: https://doi.org/10.1111/j.1542-4758.2008.00307.x
Murphy EL, Murtagh FE, Carey I, Sheerin NS. Understanding symptoms in patients with advanced chronic kidney disease managed without dialysis: use of a short patient-completed assessment tool. Nephron Clin Pract. 2009;111(1):74-80. DOI: https://doi.org/10.1159/000183177
Thong MS, Van Dijk S, Noordzij M, Boeschoten EW, Krediet TR, Dekker FW, et al. Symptom clusters in incident dialysis patients: associations with clinical variables and quality of life. Nephrol Dial Transplant. 2009;24(1):225-30. DOI: https://doi.org/10.1093/ndt/gfn449
Davison SN, Jhangri GS, Johnson JA. Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: a simple assessment of symptom burden. Kidney Int. 2006;69(9):1621-5. DOI: https://doi.org/10.1038/sj.ki.5000184
Weisbord SD, Fried LF, Arnold RM, Fine MJ, Levenson DJ, Peterson RA, et al. Prevalence, severity and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol. 2005;16(8):2487-94. DOI: https://doi.org/10.1681/ASN.2005020157
Dirschnabel AJ, Martins Ade S, Dantas SA, Marina OR, Gregio AMT, Trevilatto PC, et al. Clinical oral findings in dialysis and kidney-transplant patients. Quintessence Int. 2011;42(2):127-33.
Chuang SF, Sung JM, Kuo SC, Huang JJ, Lee SY. Oral and dental manifestations in diabetic and nondiabetic uremic patients receiving hemodialysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99(6):689-95. DOI: https://doi.org/10.1016/j.tripleo.2004.06.078
Rosa García E, Mondragón Padilla A, Aranda Romo S, Ramirez MAB. Oral mucosa symptoms, signs and lesions, in end stage renal disease and non-end stage renal disease diabetic patients. Med Oral Patol Oral Cir Bucal. 2006;11(6):467-73.
Bots CP, Brand HS, Veerman EC, Benz MV, Amerongen BMV, Valentijn RM, et al. Interdialytic weight gain in patients on hemodialysis is associated with dry mouth and thirst. Kidney Int. 2004;66(4):1662-8. DOI: https://doi.org/10.1111/j.1523-1755.2004.00933.x
Kho HS, Lee SW, Chung SC, Kim YKl. Oral manifestations and salivary flow rate, pH and buffer capacity in patients with end-stage renal disease undergoing hemodialysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88(3):316-9. DOI: https://doi.org/10.1016/S1079-2104(99)70035-1
Bots CP, Brand HS, Poorterman JH, Amerongen BMV, Benz MV, Veerman EC, et al. Oral and salivary changes in patients with end stage renal disease (ESRD): a two-year follow-up study. Br Dent J. 2007;202(2):3. DOI: https://doi.org/10.1038/bdj.2007.47
Kao CH, Hsieh JF, Tsai SC, Ho YJ, Chang HR. Decreased salivary function in patients with end-stage renal disease requiring hemodialysis. Am J Kidney Dis. 2000;36(6):1110-4. DOI: https://doi.org/10.1053/ajkd.2000.19810
Murtagh FE, Addington-Hall J, Edmonds P, Paul D, Carey I, Jenkins K et al. Symptoms in the month before death for stage 5 chronic kidney disease patients managed without dialysis. J Pain Symptom Manage. 2010;40(3):342-52. DOI: https://doi.org/10.1016/j.jpainsymman.2010.01.021
Bots CP, Brand HS, Veerman EC, Benz MV, Barbara MVA, Amerongen AVN, et al. The management of xerostomia in patients on haemodialysis: comparison of artificial saliva and chewing gum. Palliat Med. 2005;19(3):202-7. DOI: https://doi.org/10.1191/0269216305pm1009oa
Jagodzińska M, Zimmer-Nowicka J, Nowicki M. Three months of regular gum chewing neither alleviates xerostomia nor reduces overhydration in chronic hemodialysis patients. J Ren Nutr. 2011;21(5):410-7. DOI: https://doi.org/10.1053/j.jrn.2010.08.002
Orellana MF, Lagravère MO, Boychuk DG, Major PW, Mir CF.Prevalence of xerostomia in population-based samples: a systematic review. J Public Health Dent. 2006;66(2):152-8. DOI: https://doi.org/10.1111/j.1752-7325.2006.tb02572.x
Downloads
Published
How to Cite
Issue
Section
